343 related articles for article (PubMed ID: 9631007)
21. Enhanced RNase H activity with methylphosphonodiester/phosphodiester chimeric antisense oligodeoxynucleotides.
Giles RV; Tidd DM
Anticancer Drug Des; 1992 Feb; 7(1):37-48. PubMed ID: 1311929
[TBL] [Abstract][Full Text] [Related]
22. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
Fukuma T; Walton CM; Wu CH; Wu GY
Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739
[TBL] [Abstract][Full Text] [Related]
23. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.
Liu Y; Braasch DA; Nulf CJ; Corey DR
Biochemistry; 2004 Feb; 43(7):1921-7. PubMed ID: 14967032
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides.
Park WS; Miyano-Kurosaki N; Abe T; Takai K; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 2000 Apr; 270(3):953-60. PubMed ID: 10772932
[TBL] [Abstract][Full Text] [Related]
25. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
26. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
Branch AD
Hepatology; 1996 Dec; 24(6):1517-29. PubMed ID: 8938189
[TBL] [Abstract][Full Text] [Related]
27. LNA-antisense rivals siRNA for gene silencing.
Jepsen JS; Wengel J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
[TBL] [Abstract][Full Text] [Related]
28. Analysis of RNA-protein complexes by oligonucleotide-targeted RNase H digestion.
Günzl A; Palfi Z; Bindereif A
Methods; 2002 Feb; 26(2):162-9. PubMed ID: 12054893
[TBL] [Abstract][Full Text] [Related]
29. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines.
Wagner RW; Matteucci MD; Lewis JG; Gutierrez AJ; Moulds C; Froehler BC
Science; 1993 Jun; 260(5113):1510-3. PubMed ID: 7684856
[TBL] [Abstract][Full Text] [Related]
30. PAcM-AN: poly (N-acryloylmorpholine)-conjugated antisense oligonucleotides.
Bonora GM; De Franco AM; Rossin R; Veronese FM; Ferruti P; Plyasunova O; Vorobjev PE; Pyshnyi DV; Komarova NI; Zarytova VF
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1281-8. PubMed ID: 11097058
[TBL] [Abstract][Full Text] [Related]
31. Control of gene expression in viruses and protozoan parasites by antisense oligonucleotides.
Toulmé JJ; Bourget C; Compagno D; Yurchenko L
Parasitology; 1997; 114 Suppl():S45-59. PubMed ID: 9309768
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligonucleotide derivatives as gene-targeted drugs.
Knorre DG; Vlassov VV
Biomed Sci; 1990 Apr; 1(4):334-43. PubMed ID: 1723003
[TBL] [Abstract][Full Text] [Related]
33. Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer.
Fluiter K; Mook OR; Vreijling J; Langkjaer N; Højland T; Wengel J; Baas F
Mol Biosyst; 2009 Aug; 5(8):838-43. PubMed ID: 19603119
[TBL] [Abstract][Full Text] [Related]
34. [Antisense oligonucleotide inhibition of coxsackievirus B3 gene expression in HeLa cells and dose-response experiments].
Liu ZW; Sun HM; Xiao ZH; Qiu N; Zhang T; Zhao JM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):62-5. PubMed ID: 15340530
[TBL] [Abstract][Full Text] [Related]
35. Chemically modified oligonucleotides with efficient RNase H response.
Vester B; Boel AM; Lobedanz S; Babu BR; Raunkjaer M; Lindegaard D; Raunak ; Hrdlicka PJ; Højland T; Sharma PK; Kumar S; Nielsen P; Wengel J
Bioorg Med Chem Lett; 2008 Apr; 18(7):2296-300. PubMed ID: 18356048
[TBL] [Abstract][Full Text] [Related]
36. Comparison of anti-RNA properties of normal and ellipticine functionalized alpha and beta-oligonucleotides.
Lavignon M; Bertrand JR; Porumb H; Rayner B; Imbach JL; Paoletti C; Malvy C
Nucleic Acids Symp Ser; 1991; (24):117-9. PubMed ID: 1668683
[TBL] [Abstract][Full Text] [Related]
37. Antisense inhibition of Escherichia coli RNase P RNA: mechanistic aspects.
Gruegelsiepe H; Willkomm DK; Goudinakis O; Hartmann RK
Chembiochem; 2003 Oct; 4(10):1049-56. PubMed ID: 14523923
[TBL] [Abstract][Full Text] [Related]
38. Induction of RNase H activity by Arabinose-peptide nucleic acid chimeras.
Pâtureau BM; Hudson RH; Damha MJ
Bioconjug Chem; 2007; 18(2):421-30. PubMed ID: 17373768
[TBL] [Abstract][Full Text] [Related]
39. Hybridization of antisense reagents to RNA.
Sohail M; Southern EM
Curr Opin Mol Ther; 2000 Jun; 2(3):264-71. PubMed ID: 11249620
[TBL] [Abstract][Full Text] [Related]
40. Properties of nicked and circular dumbbell RNA-DNA chimeric oligonucleotides.
Yamakawa H; Hosono K; Ishibashi T; Takai K; Takaku H
Nucleic Acids Symp Ser; 1995; (34):133-4. PubMed ID: 8841588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
